JAMES HARDIE INDUSTRIES PLC (JHX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

JHX

JHX - JAMES HARDIE INDUSTRIES PLC

FNArena Sector : Building Products & Services
Year End: March
GICS Industry Group : Materials
Debt/EBITDA: 1.17
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

James Hardie Industries is a global building materials company and the largest global manufacturer of fibre cement products. Founded in 1888 it first listed on the Sydney Stock Exchange in 1951. It is now dual-listed on the Australian and New York Stock Exchanges. Management operates from Chicago, Illinois, USA.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$30.21

15 Sep
2025

0.070

OPEN

$30.10

0.23%

HIGH

$30.16

776,458

LOW

$29.84

TARGET
$35.883 18.8% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ACF . BKW . BRI . FBR . FBU . JLG . MGH . RWC . SFC . SRG . WGN .
FNARENA'S MARKET CONSENSUS FORECASTS
JHX: 1
Title FY26
Forecast
FY27
Forecast
EPS (cps) 124.2 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 24.1 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.03%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.03

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/05 - ex-div 32.66c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic 80.182.7139.7168.3177.0150.9
DPS All 14.789.972.70.00.00.0
Sales/Revenue 3,828.7 M4,060.7 M4,892.1 M5,526.1 M5,987.0 M5,946.4 M
Book Value Per Share 381.7313.5398.6544.3656.9807.0
Net Operating Cash Flow 648.7 M1,085.3 M1,022.2 M876.5 M1,360.8 M1,198.9 M
Net Profit Margin 9.26 %9.03 %12.70 %13.56 %12.96 %10.93 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed 23.16 %23.79 %39.23 %35.83 %29.53 %20.58 %
Return on Invested Capital 9.73 %11.17 %22.11 %21.07 %17.77 %12.99 %
Return on Assets 5.79 %6.14 %11.28 %12.14 %10.92 %8.17 %
Return on Equity 23.16 %23.79 %39.23 %35.83 %29.53 %20.58 %
Return on Total Capital 20.03 %26.85 %38.96 %31.94 %32.45 %26.10 %
Free Cash Flow ex dividends 131.2 M930.7 M18.3 M-178.2 M677.4 M551.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt 24 M12 M18 M28 M42 M52 M
Long Term Debt 2,283 M1,200 M1,254 M1,675 M1,803 M1,887 M
Total Debt 2,307 M1,211 M1,272 M1,703 M1,846 M1,939 M
Goodwill - Gross -275 M--295 M311 M
Cash & Equivalents - Generic 339 M453 M521 M487 M911 M1,254 M
Price To Book Value 4.8512.7110.195.859.384.77

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex 284.6 M154.5 M348.9 M865.1 M683.4 M647.5 M
Capex % of Sales 7.43 %3.81 %7.13 %15.65 %11.41 %10.89 %
Cost of Goods Sold 2,457 M2,592 M3,114 M3,607 M3,571 M3,638 M
Selling, General & Admin. Exp & Other 639 M582 M677 M777 M988 M990 M
Research & Development 48 M48 M51 M58 M71 M74 M
Investments - Total 0 M0 M0 M54 M0 M0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

21/08/2025

3

Downgrade to Neutral from Buy

$36.00

19.17%

James Hardie Industries' first quarter underlying profit declined -29% year on year, -19% below consensus. The miss was due to a North American earnings result -17% below given a more challenged volume environment, UBS notes.

Those volumes were down -14% with the company noting that volumes in its core Southern states market (60% of exteriors) were down more than -20%.

Persistently high rates and tariff volatility, alongside ongoing affordability challenges, are also driving the lower demand environment, with homebuilders reducing production rates.

Longer term, UBS  continues to expect James Hardie to benefit from the structural underbuild of US housing and ongoing material conversion across siding and decking. However, in the short term, the broker sees increased risk on earnings.

Downgrade to Neutral from Buy, target falls to $36 from $50.

FORECAST
UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of 122.52 cents.
UBS forecasts a full year FY27 dividend of 0.00 cents and EPS of 176.80 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

5

xxxxxxxxx xx xxxx xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

25/08/2025

2

Overweight

$38.00

25.79%

James Hardie Industries' 1Q25 sales of US$900m missed consensus by -8%, and adjusted EBITDA margin fell -370bps to 25.1%. Jarden notes the revised FY26 guidance suggests -20% downgrade to consensus adjusted EBITDA forecasts.

The major surprise for the broker was channel destocking with the pace sharper than seen before by the broker. Volume decline reflects the company's overweight exposure to US Sunbelt market and single-family housing starts, which are very weak currently.

The broker believe the Azek deal is unlikely to be EPS accretive in its first full year -- FY27. Balance sheet is a priority with current leverage at 3.5x vs less than 2% target within two years of Azek acquisition.

Overweight. Target cut to $38 from $44.

FORECAST
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 119.88 cents.
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 198.36 cents.

JHX STOCK CHART